Medical devices having fluorine-containing polymer coatings with improved adhesion
According to an aspect of the present invention, medical devices are provided which include a metallic substrate and a polymeric region disposed over and in contact with the metallic substrate. The polymeric region includes (a) a fluorine-containing polymer that contains at least one type of fluorine-containing monomer selected from a vinylidene fluoride monomer, a hexafluoropropylene monomer, and a combination thereof, and (b) an adhesion promoting copolymer that contains (i) at least one type of first monomer that covalently or non-covalently bonds with the metallic substrate and (ii) at least one type of second monomer selected from acrylate monomers, methacrylate monomers, fluorine-containing monomers, and combinations thereof.
1. A medical device comprising: a metallic substrate and a polymeric region disposed over and in contact with the metallic substrate, said polymeric region comprising (1) a fluorine-containing polymer which is a random copolymer of vinylidene fluoride and hexafluoropropylene and (2) an adhesion promoting copolymer that comprises (i) a first monomer which is an acidic monomer that non-covalently bonds with the metallic substrate and (ii) n-butyl acrylate as a second monomer.
2. The medical device of claim 1 , wherein said medical device is an implantable or insertable medical device.
3. The medical device of claim 1 , wherein said substrate is a metallic stent.
4. The medical device of claim 1 , wherein said substrate is a metallic stent and wherein the polymeric region covers an outer abluminal surface of the stent, but not an inner luminal surface of the stent.
5. The medical device of claim 1 , wherein said metallic substrate is selected from the group consisting of a stainless steel substrate, a platinum enriched stainless steel substrate, a nitinol substrate, and a substrate comprising cobalt and chromium.
6. The medical device of claim 1 , wherein the first monomer comprises an acidic group selected from the group consisting of a carboxylic acid group, a carboxylic acid anhydride group, a hydroxyl acid group, a sulfonic acid group, a phosphonic acid group and combinations thereof.
7. The medical device of claim 6 , wherein said first monomer is selected from the group consisting of an acrylic acid monomer, a methacrylic acid monomer, a maleic acid monomer, a maleic anhydride monomer, and combinations thereof.
8. The medical device of claim 1 , wherein said adhesion promoting copolymer further comprises a methyl methacrylate monomer.
9. The medical device of claim 1 , wherein said polymeric region comprises a polymeric layer disposed over and in contact with said metallic substrate, said polymeric layer comprising said fluorine-containing polymer and said adhesion promoting copolymer.
10. The medical device of claim 1 , wherein said polymeric region comprises (a) an adhesion promoting layer comprising said adhesion promoting copolymer disposed over and in contact with said metallic substrate, and (b) a polymeric layer comprising said fluorine-containing polymer disposed over and in contact with said adhesion promoting layer.
11. The medical device of claim 1 , wherein said polymeric region further comprises a drug.
12. The medical device of claim 11 , wherein said drug is selected from the group consisting of antiproliferative agents, anti-restenotic agents, antithrombotic agents, endothelial cell growth promoters, antimicrobial agents, analgesic agents, and anti-inflammatory agents.
13. The medical device of claim 1 , wherein said first monomer comprises a carboxylic acid group.
14. The medical device of claim 1 , wherein said first monomer is selected from the group consisting of an acrylic acid monomer, a methacrylic acid monomer, a maleic acid monomer, and combinations thereof.
15. The medical device of claim 1 , wherein said adhesion promoting copolymer further comprises an alkyl methacrylate monomer.
16. A medical device comprising: a metallic substrate and a polymeric region disposed over and in contact with the metallic substrate, said polymeric region comprising (a) an adhesion promoting copolymer that comprises an acrylic acid monomer as a first monomer and a second monomer selected from the group consisting of alkyl acrylate monomers, alkyl methacrylate monomers, and combinations thereof, and (b) a fluorine-containing polymer that comprises a combination of vinylidene fluoride monomer and hexafluoropropylene monomer.
17. The medical device of claim 16 , wherein said second monomer is an n-butyl acrylate monomer.
18. The medical device of claim 16 , wherein said second monomer is a combination of an n-butyl acrylate monomer and a methyl methacrylate monomer.
19. The medical device of claim 18 , wherein said device is not completely coated with said polymeric region.
20. The medical device of claim 16 , wherein said second monomer is an alkyl methacrylate monomer-.
21. The medical device of claim 16 , wherein said second monomer is a methyl methacrylate monomer.
22. The medical device of claim 16 , wherein said second monomer is a combination of an alkyl acrylate monomer and an alkyl methacrylate monomer.
23. A medical device comprising: a metallic substrate and a polymeric region disposed over and in contact with the metallic substrate, said polymeric region comprising (1) a fluorine-containing polymer which is a random copolymer of vinylidene fluoride and hexafluoropropylene and (2) an adhesion promoting copolymer that comprises (i) an acidic monomer that non-covalently bonds with the metallic substrate and (ii) an alkyl methacrylate monomer.
24. The medical device of claim 23 , wherein said alkyl methacrylate monomer is methyl methacrylate monomer.
25. The medical device of claim 23 , wherein said adhesion promoting copolymer further comprises an alkyl acrylate monomer.